Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Humana (HUM) is the featured stock in August's Exec Comp Aligned with ROIC Model Portfolio.
Expanding customer base, contract wins and a rapidly growing aging U.S. population will likely drive the performances of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to
Humana (HUM) makes Interwell's extensive resources available to its MA members grappling with CKD and ESKD, and hence bring about better health outcomes for them.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a pre

Should You Buy This Blue Chip Dividend Stock?

05:51am, Wednesday, 16'th Aug 2023
Humana's revenue and earnings jumped in the second quarter. The company's small dividend has exceptional growth potential.

2 Best Healthcare Stocks to Buy Right Now

09:01am, Monday, 14'th Aug 2023
Abbott Laboratories and Humana are both leaders in their respective industries with respectable growth potential. The two companies each pay safe and growing dividends to shareholders.

Final Trades: Humana, FleetCor & more

02:09pm, Wednesday, 09'th Aug 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Despite its recent rise, HUM stock appears to have more room for growth, as discussed below This 35% rise in HUM stock since late 2019 can be attributed to 1.

3 Top Healthcare Stocks to Buy for August

09:15am, Saturday, 05'th Aug 2023
Humana delivered better-than-expected second-quarter earnings. Vertex Pharmaceuticals has three potential blockbuster therapies on the way.
When it comes to building a portfolio with resilience and growth potential, the mantra to buy long-term stocks continues to resonate with seasoned investors. The art of looking beyond short-term turbu
Humana said it paid out fewer-than-expected claims for non-urgent surgery, and that helped the health insurer record better-than-expected second quarter profit.
Humana shares surge as the company beat earnings expectations on revenue and profits for its second quarter. The company's Medicare Advantage enrollment also grew by 825,000 members.
Humana's (HUM) Q2 results gain from strong pharmacy revenues and revenue growth within the Insurance segment, partly offset by higher benefits expenses.
Humana Inc. ( HUM , Financial) is a leading healthcare company that operates in the Healthcare Plans industry. As of August 2, 2023, the company's stock price stands at $482.89, with a market capitali
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE